Cefuroxime axetil clinical trials
How each study uses cefuroxime axetil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the cefuroxime axetil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 28 Dec 1987 · CEFTIN · NDA 050605 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- cefuroxime axetil
- 2
Studies by the year they started
5 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2006 | 2 |
| 2018 | 1 |
| 2021 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 5
University Medical Centre Ljubljana (2) · Dr. Promise Tamunoipiriala Jaja (1) · Hospital de Clinicas de Porto Alegre (1) · Omri Schwarztuch Gildor (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses cefuroxime axetil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- Clinical Trial Comparing Oral Versus Intravenous Cefuroxime in Pregnant Women with PyelonephritisRecruitingPhase 4Hospital de Clinicas de Porto AlegreNCT06527560Written as Cefuroxime Axetil
- Cefuroxime vs Ceftriaxone for SSI Prevention in NeurosurgeryCompletedPhase 2Dr. Promise Tamunoipiriala JajaNCT05398081Written as Cefuroxime (Zinnat®)
- Does Antibiotic Prophylaxis at Urinary Catheter Removal Prevent Urinary Tract InfectionsStatus unknownNot applicableOmri Schwarztuch GildorNCT05577273Written as Cefuroxime axetil (trimethoprim/sulfamethoxazole if penicillin allergy)
- Comparison of Doxycycline and Cefuroxime Axetil in Erythema MigransCompletedNot applicableUniversity Medical Centre LjubljanaNCT03584919Written as Cefuroxime Axetil 500Mg Tab
- Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological OutcomeCompletedPhase 4University Medical Centre LjubljanaNCT01518192Written as cefuroxime axetil
Codes
What other systems call cefuroxime axetil · ClinicalTrials.gg INT003136
- MeSH (NLM) C040738cefuroxime axetilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) Z49QDT0J8ZCEFUROXIME AXETILConfirmed FDA, NLM, Wikidata
- RxNorm 20493Confirmed FDA, Wikidata
- Wikidata Q3604308cefuroxime axetilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C28918Cefuroxime AxetilOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C040738 | cefuroxime axetil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | Z49QDT0J8Z | CEFUROXIME AXETIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 20493 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3604308 | cefuroxime axetil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C28918 | Cefuroxime Axetil | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.